This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

BI 754091

Boehringer Ingelheim GmbH

Drug Names(s): BI754091

Description: BI 754091 is an immune checkpoint inhibitor that targets PD-1 tumor cells.


BI 754091 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug